Want to join the conversation?
$LH announced availability of new application for companion diagnostic associated with use of Tarceva for treatment of non-small cell lung cancer (NSCLC). The Roche cobas EGFR Mutation Test v2 is first blood-based test approved for clinical use in U.S. to detect certain epidermal growth factor receptor gene mutations in NSCLC patients.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.